Cardiovascular morbidity and all-cause mortality in patients with retinal vein occlusion: a Danish nationwide cohort studyKatrine Hartmund Frederiksen, Lonny Stokholm, Peter Hartmund Frederiksen, Christina Mørup Jørgensen, Sören Möller, Ryo Kawasaki, Tunde Peto, Jakob Grauslund
10 May 2022
Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trialsJason Q Core, Peiying Hua, Ebenezer Daniel, Juan E Grunwald, Glenn Jaffe, Maureen G Maguire, Gui-shuang Ying, David F. Williams, Sara Beardsley, Steven Bennett, Herbert Cantrill, Carmen Chan-Tram, Holly Cheshier, John Davies, Sundeep Dev
See the full list of authors15 April 2022
Epimacular brachytherapy for previously treated neovascular age-related macular degeneration: month 36 results of the MERLOT randomised controlled trialTimothy L Jackson, Cristina Soare, Caroline Petrarca, Andrew Simpson, James E Neffendorf, Robert Petrarca, Katherine Alyson Muldrew, Tunde Peto, Usha Chakravarthy, Luke Membrey, Richard Haynes, Mark Costen, David H W Steel, Riti Desai, Fiona Bishop
See the full list of authors25 February 2022
Hemiretinal vein occlusion 12-month outcomes are unique with vascular endothelial growth factor inhibitors: data from the Fight Retinal Blindness! RegistryAdrian Robert Hunt, Vuong Nguyen, Jennifer J Arnold, Ian L McAllister, Hemal Mehta, Alessandro Invernizzi, Theodorus Ponsioen, Pierre-Henry Gabrielle, Louise O'Toole, Pavol Kusenda, Socorro Alforja, Daniel Barthelmes, Mark C Gillies
25 January 2022
Intravitreal antivascular endothelial growth factor in diabetic macular oedema: scoping review of clinical practice guidelines recommendationsManuel Vargas-Peirano, Catalina Verdejo, Laura Vergara-Merino, Cristóbal Loézar, Martin Hoehmann, Javier Pérez-Bracchiglione
14 December 2021
Preincubation of donor tissue with a VEGF cytokine trap promotes subsequent high-risk corneal transplant survivalWei Zhang, Alfrun Schönberg, Matthias Hamdorf, Tihomir Georgiev, Claus Cursiefen, Felix Bock
22 November 2021
OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based studySimon KH Szeto, Vivian W. K. Hui, Fang Yao Tang, Dawei Yang, Zi han Sun, Shaheeda Mohamed, Carmen K M Chan, Timothy Y Y Lai, Carol Cheung
8 November 2021
Morphological characteristics of eyes with neovascular age-related macular degeneration and good long-term visual outcomes after anti-VEGF therapyMengyuan Fang, Karntida Chanwimol, Jyotsna Maram, Ghazala A Datoo O'Keefe, Charles C Wykoff, David Sarraf, A’sha Brown, Shaun Ian Retief Lampen, Brenda Zhou, Alexander M Rusakevich, SriniVas Sadda
24 September 2021
Predicting the immediate impact of national lockdown on neovascular age-related macular degeneration and associated visual morbidity: an INSIGHT Health Data Research Hub for Eye Health reportSusan P Mollan, Dun Jack Fu, Ching-Yi Chuo, Jacqueline G Gannon, Wen Hwa Lee, J Jill Hopkins, Cian Hughes, Alastair K Denniston, Pearse A Keane, Ronald Cantrell
13 September 2021
Contrast sensitivity and quality of life following intravitreal ranibizumab injection for central retinal vein occlusionTomoya Murakami, Fumiki Okamoto, Yoshimi Sugiura, Shohei Morikawa, Yoshifumi Okamoto, Takahiro Hiraoka, Tetsuro Oshika
27 August 2021